Lumexa Imaging Holdings, Inc. SEC filings LMRI
Lumexa Imaging Holdings, Inc. has 71 filings in SEC EDGAR's recent list, going back to Jun 12, 2025. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 30, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2026 | May 12, 2026 |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 9, 2026 | Apr 8, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 26, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 2, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 25, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 13, 2026 | — |
| 4 | Insider transaction | Jan 15, 2026 | Dec 12, 2025 |
| 3 | Initial insider ownership | Jan 15, 2026 | Dec 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 15, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Dec 30, 2025 | Dec 12, 2025 |
| 3 | Initial insider ownership | Dec 30, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 18, 2025 | Dec 17, 2025 |
| 3 | Initial insider ownership | Dec 18, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 3 | Initial insider ownership | Dec 15, 2025 | Dec 11, 2025 |
| 3 | Initial insider ownership | Dec 15, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Material agreement, Officer or director change, Bylaw or fiscal year change, Other events
|
Dec 12, 2025 | Dec 12, 2025 |
| S-8 | Employee stock plan registration | Dec 12, 2025 | — |
| 424B4 | Prospectus | Dec 12, 2025 | — |
| 3 | Initial insider ownership | Dec 11, 2025 | Dec 11, 2025 |
| 3 | Initial insider ownership | Dec 11, 2025 | Dec 11, 2025 |
| 3 | Initial insider ownership | Dec 11, 2025 | Dec 11, 2025 |
| 3 | Initial insider ownership | Dec 11, 2025 | Dec 11, 2025 |
| 3 | Initial insider ownership | Dec 11, 2025 | Dec 11, 2025 |
| 3 | Initial insider ownership | Dec 11, 2025 | Dec 11, 2025 |
| 3 | Initial insider ownership | Dec 11, 2025 | Dec 11, 2025 |
| 3 | Initial insider ownership | Dec 11, 2025 | Dec 11, 2025 |
| 3 | Initial insider ownership | Dec 11, 2025 | Dec 11, 2025 |
| CERT | Filing | Dec 11, 2025 | — |
| 8-A12B | Filing | Dec 11, 2025 | — |
| EFFECT | Filing | Dec 10, 2025 | — |
| CORRESP | Letter to the SEC | Dec 8, 2025 | — |
| CORRESP | Letter to the SEC | Dec 8, 2025 | — |
| CORRESP | Letter to the SEC | Dec 2, 2025 | — |
| S-1/A | Amended registration statement | Dec 2, 2025 | — |
| UPLOAD | Letter from the SEC | Nov 24, 2025 | — |
| CORRESP | Letter to the SEC | Nov 24, 2025 | — |
| S-1 | Registration statement | Nov 17, 2025 | — |
| DRSLTR | Filing | Oct 10, 2025 | — |
| DRS/A | Filing | Oct 10, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 26, 2025 | — |
| DRSLTR | Filing | Sep 12, 2025 | — |
| DRS/A | Filing | Sep 12, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2025 | — |
| DRSLTR | Filing | Aug 7, 2025 | — |
| DRS/A | Filing | Aug 7, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 9, 2025 | — |
| DRS | Filing | Jun 12, 2025 | — |
Showing 71 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- LMRI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Raleigh, NC
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 2071288
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.